Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis

BACKGROUND: Recent evidence suggests that biologic therapy with targeted activity within the Type 2 inflammatory pathway can improve the clinical signs and symptoms of chronic rhinosinusitis with nasal polyposis (CRSwNP). There remains a population in CRSwNP that despite medical therapy and endoscop...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Otolaryngol Head Neck Surg
Egile Nagusiak: Thamboo, Andrew, Kilty, S., Witterick, I., Chan, Y., Chin, C. J., Janjua, A., Javer, A., Lee, J., Monterio, E., Rotenberg, B., Scott, J., Smith, K., Sommer, D. D., Sowerby, L., Tewfik, M., Wright, E., Desrosiers, M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2021
Gaiak:
Original Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7945300/
https://ncbi.nlm.nih.gov/pubmed/33750471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40463-021-00493-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak